The Aperlena Verdict
Open raceNo supplier dominates: 254 different companies have won the last 661 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- Expected final price vs the published estimate
- 0%
Based on 661 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThis tender concerns the supply of test kits for the detection of human haemoglobin in faeces. The contracting authority intends to purchase diagnostic reagents or rapid tests used to identify the presence of hidden blood in stool samples, a screening application commonly used in colorectal cancer detection programmes and general clinical diagnostics. The procurement covers the acquisition of these in vitro diagnostic products for laboratory use. No lots are described in the notice text; the procurement relates to the acquisition of the haemoglobin in faeces detection tests as a single supply requirement.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 2 days ago
The official portal may ask for a free registration before downloading.
More from this buyer
Full buyer profile124 open tenders right now
- Hospital use clothing - 264A000028 - Purchase of staff uniforms for 2026 and 2027 1 day left
- Consumable medical devices - 262A000195 - Acquisition of Medical Devices for Traumatology (encavilhamento), 2026 and 2027 3 days left
- Software development services for databases - Acquisition of application support and maintenance services for an SAP solution for 2026, 2027, 2028 and 2029 20 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| GENERIS FARMACÊUTICA S.A | 17 | €146,661 | Sep 2026 |
| ACCORD HEALTHCARE UNIPESSOAL LDA | 16 | €363,988 | Aug 2026 |
| FRESENIUS KABI PHARMA PORTUGAL, LDA. | 16 | €313,366 | Sep 2026 |
| GENERIS - FARMACEUTICA, S.A. | 15 | €357,803 | Sep 2026 |
| XPHARMA, Lda. | 14 | €51,218 | Sep 2026 |
Based on 661 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 666 comparable contracts this buyer awarded in this sector over the last 4 years.
- Lower quartile
- €1,443
- Median award
- €6,981
- Upper quartile
- €28,460
This tender is estimated 1146.2% above that median
Most recent awards
- 261Y000617/13559 - IMIPENEM 500 MG + CILASTATINA 5 €102,563
- 261G001039/13559 - AC MONOCLONAL ANTI CD123-APC €810
- 261Y000618/13559 - BRIGAtinib 30 MG COMP €2,212
- 261G001021/13559 - VÁRIOS REAGENTES €810
- 261X000268 - CANABIDIOL 100MG/ML SOL ORAL FRS 100ML €17,765
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€318,040
est. value
1
day left
€604,860
est. value
1
day left
€739,727
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,101,350
- Buyer track record on Aperlena
- 2,790 notices tracked · 992 awarded
- €41,311,370 in awarded contracts
Never miss a tender like this
1,161 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert